Log in to save to my catalogue

Targeting of RRM2 suppresses DNA damage response and activates apoptosis in atypical teratoid rhabdo...

Targeting of RRM2 suppresses DNA damage response and activates apoptosis in atypical teratoid rhabdo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e574275cddf349a6bfdc6e8be6ff72fb

Targeting of RRM2 suppresses DNA damage response and activates apoptosis in atypical teratoid rhabdoid tumor

About this item

Full title

Targeting of RRM2 suppresses DNA damage response and activates apoptosis in atypical teratoid rhabdoid tumor

Publisher

England: BioMed Central Ltd

Journal title

Journal of experimental & clinical cancer research, 2023-12, Vol.42 (1), p.346-346, Article 346

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Atypical teratoid rhabdoid tumors (ATRT) is a rare but aggressive malignancy in the central nervous system, predominantly occurring in early childhood. Despite aggressive treatment, the prognosis of ATRT patients remains poor. RRM2, a subunit of ribonucleotide reductase, has been reported as a biomarker for aggressiveness and poor prognostic condit...

Alternative Titles

Full title

Targeting of RRM2 suppresses DNA damage response and activates apoptosis in atypical teratoid rhabdoid tumor

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e574275cddf349a6bfdc6e8be6ff72fb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e574275cddf349a6bfdc6e8be6ff72fb

Other Identifiers

ISSN

1756-9966,0392-9078

E-ISSN

1756-9966

DOI

10.1186/s13046-023-02911-x

How to access this item